| ²é¿´: 865 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
jijianjndxÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
×øµÈ¸ßÈË·Ò룬¹ØÓÚDNAÐòÁÐ
|
|
|
The oligonucleotide sequences used were: co-polymerized or thiolated sequence (Breast Cancer 1 (BRCA1); Exon16: 5¡®-Acrydite or 50-SH-C6 - AGG GTC ATC AGA GAA GAG G-3¡¯. The surface plasmon resonance study was carried out with complementary and non-complementary sequences matching the co-polymerized sequence in length. Short perfect match: 5¡¯-CC TCT TCT CTG ATG ACC CT-3¡®; short non-complementary sequence (control gene ampliconsequence lymphotoxin-a): 5¡®-G TCT CTT CCT CCC AAG GGT-3¡¯ . [ Last edited by jijianjndx on 2012-2-18 at 09:57 ] |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸C9µÄ»¯Ñ§¹¤³Ì£¨085602£© 340·Ö£¬¸Ð¾õУÄÚµ÷¼ÁÎÞÍû£¬Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´

wyky2007136
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 29
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 952.8
- É¢½ð: 200
- ºì»¨: 1
- Ìû×Ó: 124
- ÔÚÏß: 34.6Сʱ
- ³æºÅ: 1554009
- ×¢²á: 2011-12-28
- ÐÔ±ð: MM
- רҵ: Íâ¹úÓïÑÔ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
°®ÓëÓêÏÂ(½ð±Ò+1): 2012-02-18 12:40:20
jijianjndx(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ ¾ø¶ÔÍêÃÀ£¬°¥£¬¸Õ½Ó´¥DNA aptamerÕâ¿é£¬¿´ÎÄÏ׺þÀ½á¡£¡£ 2012-02-18 13:35:03
jijianjndx(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ ¾ø¶ÔÍêÃÀ£¬°¥£¬¸Õ½Ó´¥DNA aptamerÕâ¿é£¬¿´ÎÄÏ׺þÀ½á¡£¡£ 2012-02-18 13:35:03
|
ËùÓõĹѺËÜÕËáÐòÁÐΪ£º¹²¾ÛºÏ»òÛÏ»ù»¯ÐòÁУ¨ÈéÏÙ°©1£¨BRCA1»ùÒò£©; ÍâÏÔ×Ó16ÊÇ£º5'-Acrydite»ò50-SH-C6- AGG GTC ATC AGA GAA GAG G-3'¡£ ¶ÔÓëËùÊöµÄ¹²¾ÛºÏÐòÁÐÔÚ³¤¶ÈÉÏ»¥²¹ºÍ·Ç»¥²¹ÐòÁнøÐÐÁ˱íÃæµÈÀë×ÓÌå¹²Õñ¡£¶Ì¾øÅäΪ£º5'-CC TCT TCT CTG ATG ACC CT-3¡®;¶Ì·Ç»¥²¹ÐòÁУ¨¿ØÖÆ»ùÒòÀ©Ôö×ÓÐòÁÐÁܰͶ¾ËØ-A£©£º5¡®-G TCT CTT CCT CCC AAG GGT-3 |

2Â¥2012-02-18 12:22:03














»Ø¸´´ËÂ¥